Cilostazol Following Peripheral Endovascular Procedures

Phase 3 Unknown 200 enrolled Attikon Hospital University Hospital of Patras · collab

RandomizedParallel-groupSingle-blindPrevention

Summary

To compare the safety and effectiveness of dual anti-platelet therapy with cilostazol 100 mg twice daily and aspirin 100 mg daily versus monotherapy with aspirin 100 mg daily in patients undergoing peripheral angioplasty or stenting or both for the management of peripheral arterial disease.

Timeline

Start: 2016-12
Primary completion: 2021-12
Completion: 2021-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cilostazol	Small molecule	100 mg	—
Background	Aspirin	Small molecule	100 mg	—

Cilostazol Following Peripheral Endovascular Procedures

Summary

Timeline

Drugs

Indications